UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000002716
Receipt No. R000003311
Scientific Title A Phase II Study of Erlotinib for previously treated Non-small cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation
Date of disclosure of the study information 2009/11/06
Last modified on 2014/11/05 10:39:28

No. Disposal Last modified on Item of update
1 Insert 2009/11/05 18:46:43
2 Update 2010/05/06 14:20:15 Recruitment status
3 Update 2012/05/06 15:42:56 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2013/07/22 14:31:28 Email1
5 Update 2014/11/05 10:38:55 Email
6 Update 2014/11/05 10:39:28 Recruitment status

Contact us.